NeuroSense Therapeutics Ltd.
Hedge Funds Holdings
Last updated:
NeuroSense Therapeutics Ltd.‘s stocks are currently a part of 5 hedge funds’ portfolios, which represents 1.1% of the total amount of its stocks outstanding. This makes up a total of 123.81K shares of NeuroSense Therapeutics Ltd.. Compared to the previous quarter, the number grew by 256.87% or 89.11K shares more. As for the holding position changes, 20% (1) of current hedge fund investors increased the number of shares held, and 20% (1) closed the holdings completely. 2 hedge funds are new holders of NeuroSense Therapeutics Ltd. stock in Q1 2023, it is 40% of total holders.
Hedge funds holding NeuroSense Therapeutics Ltd. (Q4 2021 – Q1 2023)
| Q4 2021 | 5 |
|---|---|
| Q1 2022 | 7 |
| Q2 2022 | 7 |
| Q3 2022 | 4 |
| Q4 2022 | 5 |
| Q1 2023 | 5 |
Hedge funds changes in NeuroSense Therapeutics Ltd. positions (Q4 2021 – Q1 2023)
| Q4 2021 | 5 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2022 | 5 | 0 | 2 | 3 | -3 |
| Q2 2022 | 4 | 3 | 0 | 4 | -4 |
| Q3 2022 | 2 | 0 | 2 | 5 | -5 |
| Q4 2022 | 1 | 1 | 2 | 0 | 1 |
| Q1 2023 | 2 | 1 | 0 | 1 | 1 |
Top 50 hedge fund holders of NeuroSense Therapeutics Ltd. (NASDAQ:NRSN)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC Jim Simons | 97K | 54.3K | 0.000% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 30K | 16.53K | 0.001% |
| UBS GROUP AG | 3K | 1.82K | 0.000% |
| CWM, LLC | 2K | 1K | 0.000% |
| MILLENNIUM MANAGEMENT LLC Israel Englander | 0 | 0 | 0.000% |
| JANE STREET GROUP, LLC | 0 | 0 | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0 | 0 | 0.000% |
| CITIGROUP INC | 0 | 0 | 0.000% |
| CLEAR STREET LLC | 0 | 0 | 0.000% |